{"id":"https://openalex.org/W7062425268","doi":null,"title":"Una revisi\u00f3n de los avances en la terap\u00e9utica de la enfermedad de Alzheimer: estrategia frente a la prote\u00edna \u03b2-amiloide. [Review of the advances in treatment for Alzheimer disease: Strategies for combating \u03b2-amyloid protein].","display_name":"Una revisi\u00f3n de los avances en la terap\u00e9utica de la enfermedad de Alzheimer: estrategia frente a la prote\u00edna \u03b2-amiloide. [Review of the advances in treatment for Alzheimer disease: Strategies for combating \u03b2-amyloid protein].","publication_year":2018,"publication_date":"2018-02-01","ids":{"openalex":"https://openalex.org/W7062425268"},"language":"en","primary_location":{"id":"pmh:oai:urv.cat:imarina:5129102","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/20.500.11797/imarina5129102","pdf_url":"https://repositori.urv.cat/repositori/getDocument/imarina%3A5129102?ds=DocumentPrincipal&mime=application/pdf","source":{"id":"https://openalex.org/S7407055111","display_name":"Rovira & Virgili repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"NEUROLOGIA. 33 (1): 47-58","raw_type":"Journal Publications"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://repositori.urv.cat/repositori/getDocument/imarina%3A5129102?ds=DocumentPrincipal&mime=application/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Folch, J; Ettcheto, M; Petrov, D; Abad, S; Pedros, I; Marin, M; Olloquequi, J; Camins, A","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210086696","display_name":"Biomedical Research Networking Center on Neurodegenerative Diseases","ror":"https://ror.org/00zca7903","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210086696"]},{"id":"https://openalex.org/I55952717","display_name":"Universitat Rovira i Virgili","ror":"https://ror.org/00g5sqv46","country_code":"ES","type":"education","lineage":["https://openalex.org/I55952717"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Folch, J; Ettcheto, M; Petrov, D; Abad, S; Pedros, I; Marin, M; Olloquequi, J; Camins, A","raw_affiliation_strings":["Centros de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas (CIBERNED) , Instituto de Salud Carlos III , Madrid , Espa\u00f1a","Unitat de Bioqu\u00edmica , Facultat de Medicina i Ci\u00e8ncies de la Salut , Universitat Rovira i Virgili , Reus , Tarragona , Espa\u00f1a"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centros de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas (CIBERNED) , Instituto de Salud Carlos III , Madrid , Espa\u00f1a","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210086696"]},{"raw_affiliation_string":"Unitat de Bioqu\u00edmica , Facultat de Medicina i Ci\u00e8ncies de la Salut , Universitat Rovira i Virgili , Reus , Tarragona , Espa\u00f1a","institution_ids":["https://openalex.org/I55952717"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210086696","https://openalex.org/I55952717"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.34266907,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.8709999918937683},{"id":"https://openalex.org/keywords/amyloid-hypothesis","display_name":"amyloid hypothesis","score":0.7689999938011169},{"id":"https://openalex.org/keywords/beta-secretase-inhibitors","display_name":"beta-secretase inhibitors","score":0.7730000019073486},{"id":"https://openalex.org/keywords/gamma-secretase-inhibitors","display_name":"gamma-secretase inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/passive-immunotherapy","display_name":"passive immunotherapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/active-immunotherapy","display_name":"active immunotherapy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/solanezumab","display_name":"solanezumab","score":0.8799999952316284},{"id":"https://openalex.org/keywords/amyloid-fibril-formation","display_name":"amyloid fibril formation","score":0.5649999976158142},{"id":"https://openalex.org/keywords/neurodegenerative-disease-treatment","display_name":"neurodegenerative disease treatment","score":0.6069999933242798}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.63919997215271},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5910999774932861},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5027999877929688},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.3928000032901764},{"id":"https://openalex.org/C3017819807","wikidata":"https://www.wikidata.org/wiki/Q332154","display_name":"Healthy aging","level":2,"score":0.37040001153945923},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.3614000082015991},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3142000138759613},{"id":"https://openalex.org/C147077947","wikidata":"https://www.wikidata.org/wiki/Q1515895","display_name":"Socioeconomic status","level":3,"score":0.29159998893737793},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.27950000762939453},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.2492000013589859}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:urv.cat:imarina:5129102","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/20.500.11797/imarina5129102","pdf_url":"https://repositori.urv.cat/repositori/getDocument/imarina%3A5129102?ds=DocumentPrincipal&mime=application/pdf","source":{"id":"https://openalex.org/S7407055111","display_name":"Rovira & Virgili repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"NEUROLOGIA. 33 (1): 47-58","raw_type":"Journal Publications"}],"best_oa_location":{"id":"pmh:oai:urv.cat:imarina:5129102","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/20.500.11797/imarina5129102","pdf_url":"https://repositori.urv.cat/repositori/getDocument/imarina%3A5129102?ds=DocumentPrincipal&mime=application/pdf","source":{"id":"https://openalex.org/S7407055111","display_name":"Rovira & Virgili repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"NEUROLOGIA. 33 (1): 47-58","raw_type":"Journal Publications"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7062425268.pdf","grobid_xml":"https://content.openalex.org/works/W7062425268.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W294753858","https://openalex.org/W2608752954","https://openalex.org/W2740674355","https://openalex.org/W7071550457","https://openalex.org/W4380884053","https://openalex.org/W2041124516","https://openalex.org/W2438493955","https://openalex.org/W2065100984","https://openalex.org/W2965520785","https://openalex.org/W2924155929"],"abstract_inverted_index":{"Alzheimer":[0],"disease":[1,26],"(AD)":[2],"is":[3],"a":[4,65],"major":[5,28],"neurodegenerative":[6,125],"disorder":[7],"which":[8,51],"eventually":[9],"results":[10],"in":[11,33,68,108,141,152],"total":[12],"intellectual":[13],"disability.":[14],"The":[15,58,127],"high":[16],"global":[17],"prevalence":[18],"and":[19,46,85,92],"the":[20,25,34,47,54,76,83,99,110,121,142,159],"socioeconomic":[21],"burden":[22],"associated":[23],"with":[24,154],"pose":[27],"challenges":[29],"for":[30,98,119],"public":[31],"health":[32],"21st":[35],"century.":[36],"In":[37,88],"this":[38,124],"review":[39],"we":[40],"focus":[41],"on":[42],"both":[43,90],"existing":[44],"treatments":[45],"therapies":[48],"being":[49],"developed,":[50],"principally":[52],"target":[53],"\u03b2-amyloid":[55,63,79,103,139],"protein.":[56],"DISCUSSION:":[57],"amyloidogenic":[59,160],"hypothesis":[60,161],"proposes":[61],"that":[62,137,158],"plays":[64],"key":[66],"role":[67],"AD.":[69],"Several":[70],"pharmacological":[71],"approaches":[72],"aim":[73],"to":[74,163],"reduce":[75],"formation":[77],"of":[78,101,113,123,129,131],"peptides":[80],"by":[81,145],"inhibiting":[82,102],"\u03b2-secretase":[84],"\u03b3-secretase":[86],"enzymes.":[87],"addition,":[89],"passive":[91],"active":[93],"immunotherapies":[94],"have":[95],"been":[96],"developed":[97],"purpose":[100],"peptide":[104],"aggregation.":[105],"CONCLUSIONS:":[106],"Progress":[107],"identifying":[109],"molecular":[111],"basis":[112],"AD":[114],"may":[115],"provide":[116],"better":[117],"models":[118],"understanding":[120],"causes":[122],"disease.":[126],"lack":[128],"efficacy":[130],"solanezumab":[132],"(a":[133],"humanised":[134],"monoclonal":[135],"antibody":[136],"promotes":[138],"clearance":[140],"brain),":[143],"demonstrated":[144],"2":[146],"recent":[147],"Phase":[148],"III":[149],"clinical":[150],"trials":[151],"patients":[153],"mild":[155],"AD,":[156],"suggests":[157],"needs":[162],"be":[164],"revised.":[165]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-10T00:00:00"}